Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Infect Dis ; 11: 260, 2011 Sep 30.
Article in English | MEDLINE | ID: mdl-21961922

ABSTRACT

BACKGROUND: Intravesical instillation of Bacillus Calmette-Guérin (BCG) is the treatment of choice for superficial bladder carcinoma. Complications of BCG therapy include local infections and disseminated BCG infection with multiple endorgan complications. CASE PRESENTATION: We report a case of disseminated, post-treatment BCG infection that initially presented with granulomatous hepatitis and choroiditis. After successful anti-mycobacterial therapy and resolution of the hepatic and ocular abnormalities, the patient developed an acute upper gastrointestinal hemorrhage from an aortoduodenal fistula that required emergency surgery. The resection specimen revealed multifocal, non-caseating granulomas, indicating mycobacterial involvement. CONCLUSIONS: This case highlights the varied end organ complications of disseminated BCG infection, and the need for vigilance even in immuno-competent patients with a history of intravesical BCG treatment.


Subject(s)
Biological Products/adverse effects , Choroiditis/diagnosis , Fistula/diagnosis , Gastrointestinal Hemorrhage/diagnosis , Granulomatous Disease, Chronic/diagnosis , Hepatitis/diagnosis , Mycobacterium bovis/pathogenicity , Administration, Intravesical , Antitubercular Agents/administration & dosage , Aorta/pathology , Biological Products/administration & dosage , Carcinoma/therapy , Choroiditis/complications , Choroiditis/microbiology , Choroiditis/pathology , Duodenum/pathology , Fistula/complications , Fistula/microbiology , Fistula/pathology , Gastrointestinal Hemorrhage/complications , Gastrointestinal Hemorrhage/microbiology , Gastrointestinal Hemorrhage/pathology , Granulomatous Disease, Chronic/complications , Granulomatous Disease, Chronic/microbiology , Granulomatous Disease, Chronic/pathology , Hepatitis/complications , Hepatitis/microbiology , Hepatitis/pathology , Humans , Male , Middle Aged , Mycobacterium bovis/immunology , Treatment Outcome , Urinary Bladder Neoplasms/therapy
2.
Mol Cell Biochem ; 251(1-2): 61-6, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14575305

ABSTRACT

Enhanced cardiac generation of peroxynitrite contributes to septic cardiomyopathy. Since matrix metalloproteinases (MMPs) are activated in vitro by peroxynitrite, we hypothezised that MMPs may contribute to cardiac mechanical dysfunction in sepsis. Rats were injected (i.p.) with either lipopolysaccharide (LPS, 4 mg/kg) or vehicle. MMP inhibitors, either Ro 31-9790 (20 mg/kg), doxycycline (4 mg/kg), or vehicle were administered i.p. 30 min after LPS. At 6 h, when the symptoms of endotoxemia peak, hearts were excised and perfused as working hearts with Krebs-Henseleit buffer at 37 degrees C. Cardiac work (cardiac output x peak systolic pressure product) was measured. Perfusate and ventricle samples were analyzed by gelatin zymography to quantify MMP activity. Cardiac function was significantly depressed in LPS-treated rats compared to control rats (control: 55 +/- 4, LPS: 26 +/- 6 mmHg*mL*min(-1)). LPS also caused a loss of 72 kDa MMP-2 activity in the ventricles and the perfusate. Although MMP-9 activity was not detected in the ventricles, LPS resulted in an increase in perfusate 92 kDa MMP-9 activity. The MMP inhibitors significantly improved cardiac function of LPS-treated rats (Ro 31-9790: 38 +/- 3, doxycycline: 51 +/- 3 mmHg*mL*min(-1)), had no effect on the loss of MMP-2 activity, and significantly reduced the MMP-9 activity in the perfusate. These results demonstrate, for the first time, that LPS induced cardiac dysfunction is associated with a loss in ventricular MMP-2 activity and the release of MMP-9 from the heart. MMP inhibitors can significantly preserve cardiac mechanical function during septic shock.


Subject(s)
Cardiomyopathies/drug therapy , Endotoxemia/drug therapy , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinase Inhibitors , Matrix Metalloproteinases/therapeutic use , Animals , Blood Pressure , Cardiac Output , Cardiomyopathies/chemically induced , Cardiomyopathies/metabolism , Doxycycline/administration & dosage , Doxycycline/pharmacology , Electrophoresis, Polyacrylamide Gel , Enzyme Activation , Hydroxamic Acids/administration & dosage , Hydroxamic Acids/pharmacology , Injections, Intraperitoneal , Lipopolysaccharides/pharmacology , Male , Perfusion , Rats , Rats, Sprague-Dawley , Time Factors
3.
Oncogene ; 22(36): 5562-71, 2003 Aug 28.
Article in English | MEDLINE | ID: mdl-12944903

ABSTRACT

We investigated the effects of metabolic labeling with [(3)H]thymidine, [(3)H]uridine, and [(14)C]thymidine on human cells in terms of cell growth, p53 signaling, and nucleotide excision repair. Labeling with [(3)H] nucleosides resulted in growth inhibition by both p53-dependent and -independent mechanisms. Tritium labeling also led to nuclear accumulation of p53 and induction of the p53-regulated gene p21(WAF1) and its encoded protein (p21). ATM-deficient cells, however, did not increase their p53 and p21 protein levels in response to radiolabeling. Thus, labeling of human cells with tritiated nucleosides activates the radiation-responsive, ATM-dependent, DNA-damage surveillance network. Labeling of normal cells with [(3)H]thymidine significantly accelerated the repair of ultraviolet (UV) light-induced cyclobutane pyrimidine dimers, as monitored by a sensitive immunofluorescence assay. Unlike [(3)H] labeling, [(14)C] labeling did not produce any impact on proliferation, p53 signaling, or DNA repair. In the light of these findings, the validity of results obtained with nucleic acid synthesis and DNA repair assays that involve [(3)H] and [(14)C] labeling is discussed. Our immunofluorescence approach detected pyrimidine dimers after exposure to UV fluences as low as 1 J/m(2) (the lowest fluence examined). This approach may prove particularly useful for monitoring DNA damage and its repair following exposure to extremely low levels of genotoxic agents.


Subject(s)
DNA Repair , Nucleosides/metabolism , Protein Serine-Threonine Kinases/physiology , Signal Transduction/physiology , Tumor Suppressor Protein p53/physiology , Ataxia Telangiectasia Mutated Proteins , Cell Cycle Proteins , Cell Division , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/analysis , DNA Damage , DNA-Binding Proteins , Fluorescent Antibody Technique , Humans , RNA, Messenger/analysis , Tritium , Tumor Suppressor Protein p53/analysis , Tumor Suppressor Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...